RadComp Newsletter October, 2021
The Importance of Diversity in Clinical Trials: A Conversation
with RadComp Advisor
Ivis Febus-Sampayo
We asked Ivis Febus-Sampayo, a two-time breast cancer survivor and the Chief Diversity Officer and Senior Director of Public Outreach at SHARE, about the resources that SHARE had developed to foster their commitment to diversity and inclusion in cancer research.

Congratulations and Heartfelt Thanks!

Congratulations to Dr. Christy Kesslering, Principal Investigator for Northwestern Medicine. She will be retiring in December to begin a new venture in the Health and Wellness industry in the New Year.

Read More
Advocacy Partner Events & Resources
Living Beyond Breast Cancer Presents
What Makes a Cancerversary?
by Michelle McGree

In her new blog, Michelle McGree talks about her experience as a young breast cancer survivor.

"If you are fortunate enough to experience a cancerversary..., you may know how emotionally complicated it can be."
Knowledge is Power Series
The Black Breast
Cancer Experience
This year's Black Breast Cancer Experience is a three part webinar, October 28th, November 4th and November 11 from 7 pm - 8:30 pm.
The Webinars are free to attend but you must register.
SHARE Breast Cancer Novela

LatinaSHARE Outreach Ambassador Program provides information on risks and symptoms of breast cancer using English and Spanish materials which are culturally appropriate and sensitive to health literacy (such as SHARE’s Novelas, which dispel myths and highlight signs, symptoms and resources).
You're Invited!
Register today for 2021 PCORI Virtual Annual Meeting
(November 17-19)

Colleagues from across the healthcare community will gather at the 2021 PCORI Virtual Annual Meeting, which will be held November 17-19. Registration is free.
 
The event will highlight results from PCORI-funded studies and explore how to advance patient-centered outcomes research and comparative clinical effectiveness research. Attendees will learn about PCORI’s efforts to disseminate study findings and engage communities in research, enjoy opportunities to network with others, and learn more about PCORI’s National Priorities for Health. The meeting’s sessions will discuss several important issues, including health equity and disparities, emerging healthcare innovations, and COVID-19-related research. 
Study Participant Enrollment
As of September 30, 990 of 1278 participants have joined the RadComp Trial, 8 in the month of September.

We are 77% of the way toward reaching our goal of complete study enrollment.

Together we can reach the goal and power the future of breast cancer treatment.
Learn About RadComp
Research reported was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-1403-12804). The views, statements, and opinions presented in this study website are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.